Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Short Interest Down 6.3% in November
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Get Free Report) saw a large decline in short interest in November. As of November 15th, there was short interest totalling 6,500,000 shares, a decline of 6.3% from the October 31st total of 6,940,000 shares. Based on an average daily trading volume, of 713,900 shares, the days-to-cover ratio is presently […]
More Stories
Headinvest LLC Invests $202,000 in Morgan Stanley (NYSE:MS)
Headinvest LLC purchased a new position in shares of Morgan Stanley (NYSE:MS – Free Report) in the 3rd quarter, according...
LRI Investments LLC Buys 1,396 Shares of Accenture plc (NYSE:ACN)
LRI Investments LLC increased its stake in Accenture plc (NYSE:ACN – Free Report) by 14.6% during the 3rd quarter, according...
Jefferies Financial Group Upgrades Kodiak Sciences (NASDAQ:KOD) to Buy
Kodiak Sciences (NASDAQ:KOD – Get Free Report) was upgraded by Jefferies Financial Group from a “hold” rating to a “buy”...
iShares Russell 1000 Growth ETF (NYSEARCA:IWF) Shares Acquired by LRI Investments LLC
LRI Investments LLC raised its position in shares of iShares Russell 1000 Growth ETF (NYSEARCA:IWF – Free Report) by 101.5%...
Hut 8 (NASDAQ:HUT) Now Covered by Analysts at Cantor Fitzgerald
Cantor Fitzgerald initiated coverage on shares of Hut 8 (NASDAQ:HUT – Get Free Report) in a research report issued to...
Myriad Genetics (NASDAQ:MYGN) Cut to “Market Perform” at Leerink Partners
Myriad Genetics (NASDAQ:MYGN – Get Free Report) was downgraded by research analysts at Leerink Partners from an “outperform” rating to...